Enara Bio Limited
Registered name: ENARA BIO LIMITED
Enara Bio Limited made £17.4m revenue and £1.3m profit in the year to 31 Dec 2023.
Enara Bio Limited’s revenue was £17.4m in the year to 31 Dec 2023, with £1.3m profit and 54 employees. The company is classified under “research and experimental development on biotechnology” and is based in Oxford.
- Status
- Active
- Location
- Oxford, South East
- Age
- 9 yrs · since 2016
- Type
- Private Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2023 |
|---|---|
| Disclosure | Full P&L |
| Profit & loss | |
| Revenue (turnover) | £17.4m |
| Gross profit | £17.4m |
| Operating profit | £1.4m |
| Profit before tax | £1.1m |
| Profit after tax | £1.3m |
| Profit (best available) | £1.3m |
| Employees (average) | 54 |
| Ratios | |
| Profit margin | 7.7% |
| Gross margin | 100% |
| Revenue per employee | £323k |
| Profit per employee | £24.8k |
| Balance sheet — indirect signals, not revenue | |
| Net assets | — |
| Source | Accounts · bulk data Aug 2025 |
How the business works
- Profit margin
- 7.7%
- Profit ÷ revenue.
- Gross margin
- 100%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £323k
- Revenue ÷ average employees.
- Profit per employee
- £24.8k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- —
- Now 54
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Similar profitable businesses
- Theradex (Europe) LimitedRedhill · Research and experimental development on biotechnology
- Revenue
- £15.2m
- Profit
- £3.1m
- Staff
- 43
- Origio LimitedFareham · Research and experimental development on biotechnology
- Revenue
- £20.1m
- Profit
- £499k
- Staff
- 82
- Charles River U.K. LimitedKent · Research and experimental development on biotechnology
- Revenue
- £22.2m
- Profit
- £18.8m
- Staff
- 129
- Sitryx Therapeutics LimitedOxford · Research and experimental development on biotechnology
- Revenue
- £23.3m
- Profit
- £4.7m
- Staff
- —
- Dna Legal LimitedFrome · Research and experimental development on biotechnology
- Revenue
- £12.5m
- Profit
- £3.2m
- Staff
- 55
- Askbio UK LtdMidlothian · Research and experimental development on biotechnology
- Revenue
- £12.5m
- Profit
- £1.8m
- Staff
- 54
Sources
Latest figures from accounts for the year to 31 Dec 2023 (profit £1.3m), from the Companies House accounts bulk data published Aug 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.